Goldman Sachs initiated coverage of Zoetis (ZTS) on October 17, 2026, assigning a Hold rating and a USD 74.00 price target. This target sits below the stock's recent trading price of approximately USD 79.32 as of mid-October, suggesting a neutral-to-negative near-term outlook from the analyst firm. Zoetis reported second-quarter 2026 revenue of USD 2.47 billion on August 6, accompanied by a decline in adjusted net income of 2 percent. Consequently, the company revised its full-year 2026 guidance to reflect organic operational revenue growth between minus 3 percent and minus 1 percent, with adjusted net income growth expected to fall between minus 9 percent and minus 5 percent. The mixed performance across business segments drove the outlook revision. While international revenue rose 6 percent and livestock revenue grew 11 percent, companion animal revenue declined by 6 percent due to competitive pressure and affordability concerns in key US categories. Diagnostics revenue provided a partial offset with a 12 percent increase during the quarter. Zoetis declared a fourth-quarter 2026 dividend of USD 0.53 per share, payable on December 1, 2026, for shareholders of record on October 30, 2026. The company is scheduled to report its third-quarter 2026 results on November 5, 2026, which will test whether the revised full-year guidance holds amidst ongoing operating pressures.